Aimee Jackson Email

Chief Scientific Officer . Atalanta Therapeutics

Current Roles

Employees:
84
Revenue:
$13M
About
We are a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing our proprietary RNA interference platform. We were founded by Anastasia Khvorova, Ph.D., Craig Mello, Ph.D., and Neil Aronin, M.D., of the RNA Therapeutics Institute at the University of Massachusetts Medical School, with a Series A funding exclusively by F-Prime Capital. We are headquartered in Boston, Mass.
Atalanta Therapeutics Address
51 Sleeper Street
Boston, MA
United States
Atalanta Therapeutics Email

Past Companies

Atalanta TherapeuticsChief Scientific Officer
miRagen Therapeutics, Inc.Vice President of Research
miRagen Therapeutics, Inc.Senior Director, Research

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.